ホーム › 非ホジキンリンパ腫 › ニューヨーク › New York City
New York City、NYにおける非ホジキンリンパ腫の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、非ホジキンリンパ腫に関する31件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
被験者募集中第1/2相
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Epco, Zanu, Ritux for R/R FL or MZL
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
被験者募集中第1相
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
被験者募集中第1相
- Columbia University, New York
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
被験者募集中第1相
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
被験者募集中第1/2相
- Research Site, New York
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
被験者募集中第1/2相
- Local Institution - 0037, New York
- Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
被験者募集中第2相
- Research Site, New York
Cord Blood Transplant in Adults With Blood Cancers
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
被験者募集中第1相
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
被験者募集中第1相
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
被験者募集中第1/2相
- Research Site, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
被験者募集中第1/2相
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
被験者募集中観察研究
- Weill Cornell Medical Center (Data Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
DALY II USA/ MB-CART2019.1 for DLBCL
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- 他3件
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
被験者募集中第2相
- Icahn School of Medicine at Mount Sinai, New York
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
被験者募集中第4相
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
被験者募集中第4相
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
Study of SGR-1505 in Mature B-Cell Neoplasms
被験者募集中第1相
- Weill Cornell, New York
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
被験者募集中早期第1相
- Memorial Sloan Kettering Cancer Center, New York
Amping up With PemJAK
被験者募集中第2相
- Columbia University Irving Medical Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
他の都市における非ホジキンリンパ腫の試験
- Houston, TX31件の研究
- Boston, MA26件の研究
- Nashville, TN21件の研究
- Philadelphia, PA20件の研究
- Baldwin Park, CA19件の研究
- Washington, DC18件の研究
- Atlanta, GA18件の研究
- Chicago, IL18件の研究
- Milwaukee, WI18件の研究
- Columbus, OH18件の研究
- Dallas, TX17件の研究
- Seattle, WA16件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。